Stock CCAP CRESCENT CAPITAL BDC, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Crescent Capital BDC, Inc.

Equities

CCAP

US2256551092

Real-time Estimate Cboe BZX
Other stock markets
 10:17:00 2024-04-24 am EDT 		5-day change 1st Jan Change
17.27 USD +0.47% Intraday chart for Crescent Capital BDC, Inc. +1.65% -0.58%
Feb. 23 Oppenheimer Adjusts Crescent Capital BDC Price Target to $19 From $18, Maintains Outperform Rating MT
Feb. 22 Transcript : Crescent Capital BDC, Inc., Q4 2023 Earnings Call, Feb 22, 2024

Strengths

  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Its low valuation, with P/E ratio at 7.79 and 8.48 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Closed End Funds

1st Jan change Capi. Investor Rating ESG Refinitiv
CRESCENT CAPITAL BDC, INC. Stock Crescent Capital BDC, Inc.
-0.58% 637M -
ARES CAPITAL CORPORATION Stock Ares Capital Corporation
+3.42% 12.58B
C
PERSHING SQUARE HOLDINGS, LTD. Stock Pershing Square Holdings, Ltd.
+7.97% 9.19B -
C-
FS KKR CAPITAL CORP. Stock FS KKR Capital Corp.
-2.90% 5.44B
D+
SPROTT PHYSICAL URANIUM TRUST FUND Stock Sprott Physical Uranium Trust Fund
+3.61% 5.36B -
D
PIMCO DYNAMIC INCOME FUND Stock PIMCO Dynamic Income Fund
+5.01% 5.15B - -
SPROTT PHYSICAL SILVER TRUST Stock Sprott Physical Silver Trust
+13.92% 4.48B - -
SPROTT PHYSICAL GOLD AND SILVER TRUST Stock Sprott Physical Gold and Silver Trust
+15.77% 4.42B - -
MACQUARIE KOREA INFRASTRUCTURE FUND Stock Macquarie Korea Infrastructure Fund
+0.88% 3.98B -
3I INFRASTRUCTURE PLC Stock 3i Infrastructure plc
+1.87% 3.76B -
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CCAP Stock
  4. Ratings Crescent Capital BDC, Inc.